Tim Moutafis – Engineer / Inventor
SensorCells, the technology at the core of a transformative therapeutic surface, were invented by Tim Moutafis and perfected with the aid of the University of Massachusetts – Lowell plastics engineering group.
Tim formed TheraTorr Medical, Inc. and created a full-sized functional therapeutic surface using over 500 independent SensorCells to support a patient’s body. The full-size prototype was used to perform extensive data collection and competitive comparative testing to validate the technology and the concept. Since each column can yield up to 6-inches, the body can sink into the surface like sinking into a deep pillow. Deeper immersion into the surface reduces the contact pressure on each and every body part because more of the patient’s total weight is spread over a greater surface area. The results of laboratory testing…a 40% reduction of dangerous tissue interface pressure over the best that the market has to offer!
The SensorCell is based on a simple mechanical device known as a rolling diaphragm. It is the basis of a totally new therapeutic bed concept that is disruptive and will transform the environment for seriously ill patients confined to a bed with burns or serious pressure ulcers.
Unfortunately Mr. Moutafis, beset with health issues, was unable to continue working full-time on his invention.
In 2018, LeviSense Medical acquired all the assets of TheraTorr Medical, including the SensorCell IP to continue this important work. Mr. Moutafis serves as an advisor to LeviSense.
Michael K McGarrity
Mr. McGarrity, who has more than 30 years of experience in the device and diagnostic healthcare industry. Michael spent 13 years with Stryker Corporation, where he served in leadership roles in marketing and strategic development, most recently including vice president of marketing for Stryker Instruments, a $1.0 B division of the Stryker Corporation.
W. Adam Hill, PhD
Dr. Hill is currently SVP for Platform Integration at HotSpot Therapeutics and General Partner at Formation Venture Engineering. Before HotSpot Therapeutics he was VP for Platform Technologies at Plexium Pharmaceuticals and Head of Screening for Novartis Institutes for BioMedical Research in Cambridge MA. His last two biotech companies raised >$200M. He sits on several technology company boards, including IonSense who recently exited in an acquisition by Bruker. Dr. Hill is a co-founder of Formation Venture Engineering, LLC, which has been bringing start ups and platform technologies in the life sciences and MedTech space to market for the past 6 years.
Donald is a C-Level executive and serial entrepreneur with an exceptional track record for creating enterprise value in mature and resource-constrained organizations. He was a managing director at both Morgan Stanley and Royal Bank of Canada holding senior capital market advisory positions in the US, Asia and Europe. Earlier he was employed with Ciba-Geigy AG in Basel Switzerland and Baxter Travenol in Deerfield, Illinois. He founded, architected and is board member of SkyLake Partners, a $50 Million real estate private equity firm based in New York.
Donald is a trustee of amfAR the Foundation for Aids Research.
Mr Bhansali is a Partner at the Formation VE Fund. Previously, after completing a 4-year stint with an investment bank, Rahul founded / co-founded 4 companies in organic food home delivery, physical commodity trade consulting, industrial safety technology, and accelerated venture investing. Recently, Mr. Bhansali was a co-founder and leader at StrongArm Tech, where he delivered a machine learning / IoT technology that is shown to produce major savings for enterprise clients.
CEO - President
Dave Bertoni is a strategic marketing professional with extensive senior management experience in multi-national corporate as well as startup environments. In the last 25-years he has brought over a dozen technical products to domestic and international markets, as well as forming and funding three high-tech startups. Mr. Bertoni founded a consulting firm, which assists medical technology and high tech firms to identify opportunities, establish clear goals, overcome difficult business challenges and achieve operational excellence.
Chief Financial Officer
Chief Financial Officer at Etiometry Inc., a predictive analytics company in healthcare. He has raised over $8M in debt and equity financings for the company. Mr. Rock has 28+ years of financial management and operations experience with a variety of large industrial companies and the last 20 years focused on life science and early stage tech companies. He was VP of Finance for Dyax Corp leading them to a successful IPO in 2000. In 2002 As a contract CFO for early stage technology and life science companies, Mr. Rock has helped raise over $45 million in private financings and successfully sold 3 businesses for his clients. He Chaired the Massachusetts Biotechnology Council’s finance committee and the Business Solutions Advisory Board for the Biotechnology Industry Organization (BIO). Mr. Rock received a BBA from University of Massachusetts – Amherst and an MBA from Rensselaer Polytechnic Institute.
Chief Commercialization Officer
O’Malley earned extensive experience of commercialization and business development of hospital bed technology as President and Chief Growth Officer of EarlySense Inc. While at EarlySense, he led commercialization of the innovative EarlySense Sensor, a contact free patient monitoring system, empowering clinicians to provide proactive patient care by detecting opportunities for intervention by clinical teams. The hospital business of EarlySense was purchased by HillRom in 2021.
O’Malley started his career spending 16-years at Siemens Medical Systems, where he was the Vice President and Division Manager of the Electromedical Division for North America.
After Siemens, Tim served as CEO of Medwave Inc., a publicly traded company for seven years, before joining le ZOLL Medical and leading the Hospital Division. After five years at ZOLL, the hospital business went from approximately 35% to over 60% market share.
Board of Advisors
Dr. Richard S Viglione
Medical and Clinical Advisor
Linda McCormack-Miller, DNP, RN, NEA-BC, is the former Senior Vice President / Chief Nursing Officer for the Mohawk Valley Health System. In this position, Linda is responsible for nursing practice, policy and procedures across the system.
Linda has more than 25 years of progressive healthcare experience. After earning her Bachelor of Science in Nursing from Seton Hall University in South Orange, New Jersey, she was commissioned as a nurse in the United States Navy. She served at the Portsmouth, Camp Lejeune and Oakland Naval Hospitals. She completed her Master of Science in Nursing from Old Dominion University in Norfolk, Virginia, and her Doctorate in Nursing from Rush University in Chicago, Illinois.
In 1993, Linda began her post-naval career at Our Lady of Lourdes Memorial Hospital in Binghamton, New York, and held a variety of positions, most recently serving as the senior vice president of Operations/chief nursing officer. She is certified by the American Nurses Credentialing Center as a Nurse Executive, Advanced.
Dan R Berlowitz, MD MPH
Dan Berlowitz, is a UMass-Lowell Professor at the Zuckerberg College of Health Sciences, Chair of Department of Public Health and Co-Director of The Center of Biomedical and Health Research in Data Sciences (CHORDS).
Dr. Berlowitz has decades of experience as a physician, researcher, educator and administrator. His research interests center on assessing and improving the quality of medical care, which led to improvements in the management of conditions as uncontrolled hypertension and pressure injuries. While serving at the VA, he received the highest honor given to a VA health services researcher, the VA’s Under Secretary’s Award for Outstanding Achievement in Health Services Research.
He was also a part of the 12-member Guideline Governance Group responsible for the recent publication of the international guideline on the prevention and treatment of pressure injuries.
A prolific author with more than 220 publications, Dr. Berlowitz serves on the Editorial Advisory Board of Advances in Skin & Wound Care and Journal of the American Geriatrics Society.
Bill Fertig is the former Director of the Spinal Cord Injury Resource Center at United Spinal Association. The United Spinal Association network of 48 chapters, 195 support groups and over 100 rehabilitation programs assisting people living with spinal cord injuries and disorders (SCI/D), their families and caregivers, clinicians and disability stakeholders. United Spinal Association has advocated for civil rights for people with disabilities, many of them returning veterans, since 1946 to improve the quality of life of Americans with spinal cord injuries or disorders.
He served twenty-five years as a municipal police officer and training sergeant. An off-duty motorcycle accident resulted in T-7 paraplegia in 1999. Bill brings his past varied experiences and twenty years living with SCI to his Information Specialist team which helps support consumers who contact the Spinal Cord Injury Resource Center after injury or disease onset.